Experts focus on myotonic dystrophy type 1 (DM1), including its underlying causes and mechanism of disease, overall prevalence, impact on patients’ lives, its multisystem symptoms, varied pace of progression, and the necessary coordination among a multi-specialty care team to improve diagnosis and ongoing patient management.
This activity is intended for neurologists, physical therapists and physiatrists, cardiologists, gastroenterologists, ophthalmologists, and respiratory specialists who are practicing in the United States, Europe, and Japan.
For CME information, please visit: https://www.francefoundation.com/9380...
This activity is supported by an independent medical educational grant from Dyne Therapeutics.
The France Foundation
コメント